Soin Neuroscience is a privately held pharmaceutical company based in Ohio that is dedicated to developing treatments for chronic medical diseases. Their research and development focus on utilizing an oral formulation of sodium nitrite, licensed from TheraVasc, Inc., to address conditions such as peripheral artery disease (PAD) and diabetic neuropathy. With a mission to combat the effects of these diseases, Soin Neuroscience aims to provide effective treatments for the millions of people suffering from these chronic conditions.
One of their key developments is the drug TV1001SR, which is being developed to aid in the treatment of pain associated with diabetic neuropathy. With the incidence of diabetes on the rise, Soin Neuroscience's research and development efforts in this area have the potential to significantly reduce pain and improve the quality of life for individuals with diabetic neuropathy. Additionally, they are also working on developing TV1001SR to help prevent and treat peripheral artery disease, a chronic disorder that affects millions of people in the United States.
Generated from the website